Washington, DC—June 25, 2008— The 2008 American Society for Microbiology (ASM) sanofi-aventis U.S. Award will be presented to Walter Stamm, Associate Director, WWAMI Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, Seattle, Washington. Supported by an unrestricted grant from sanofi-aventis U.S., this award honors outstanding accomplishment in antimicrobial chemotherapy.
Through his professional life, Dr. Stamm has worked with antimicrobial resistance for urinary tract infections, chlamydia infections, and sexually transmitted infections. He is recognized as a leader in the antimicrobial therapy of urinary tract infections and has written guidelines for the therapy of chlamydia and other STIs for the Centers for Disease Control and Prevention. Dr. Stamm has published over 300 peer-reviewed papers, about 100 book chapters, and 11 books, most of them about urinary tract infections and genital infections including the role of bacterial pathogenesis, antimicrobial susceptibility and resistance. From 1999 through 2000, Dr. Stamm was a visiting scientist for the World Health Organization in the Antimicrobial Drug Resistance and Surveillance Branch.
Dr. Stamm received his B.A. in Biological Sciences from Stanford University and his M.D. from Harvard Medical School.. He completed his residency at the University of Washington.
The sanofi-aventis U.S. Award will be presented during ASM's 48th Interscience Conference on Antimicrobial Agents and Chemotherapy/46th IDSA Annual Meeting, October 25 – October 28, 2008 in Washington, DC. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health and economic and environmental well-being.